Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP2 | P42575 | 1/20 | 0.42 |
| ▸ | FAAH | O00519 | 4/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.40 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
| ▸ | NAAA | Q02083 | 1/20 | 0.40 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.39 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.39 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.38 |
| ▸ | CNR1 | P21554 | 1/20 | 0.37 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6287219 | 0.89 | CYP2C19 (0.50) | TSHRMEN1KMT2ACYP2C19GLA | |
| SCHEMBL6290152 | 0.85 | EPHX1 (0.50) | TSHRMEN1KMT2ACYP2C19GLA | |
| SCHEMBL6290120 | 0.83 | EPHX1 (0.54) | MEN1KMT2ACYP2C19GLAKEAP1 | |
| SCHEMBL18134840 | 0.80 | CASP2 (0.64) | CASP2FAAHTSHRMEN1KMT2A | |
| SCHEMBL6902756 | 0.79 | CYP2C19 (0.46) | FAAHTSHRMEN1KMT2ACYP2C19 | |
| SCHEMBL29286451 | 0.79 | FAAH (0.66) | CASP2FAAHNAAADNM1EPHX2 | |
| SCHEMBL6125853 | 0.79 | CASP2 (0.69) | CASP2FAAHNAAADNM1EPHX2 | |
| SCHEMBL12635103 | 0.78 | CNR1 (0.51) | FAAHMEN1KMT2ANAAACNR1 | |
| SCHEMBL25792485 | 0.78 | CASP2 (0.41) | CASP2FAAHTSHRMEN1KMT2A | |
| SCHEMBL6280459 | 0.77 | MAPT (0.43) | TSHRKEAP1NFE2L2EPHX2EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170202217-A1 | ANTIBACTERIAL POLYMER, PRODUCTION METHOD THEREFOR, AND USAGE THEREOF | NATIONAL UNIVERSITY CORPORATION YAMAGATA UNIVERSITY (JP) | 2017-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170202217-A1 | ANTIBACTERIAL POLYMER, PRODUCTION METHOD THEREFOR, AND USAGE THEREOF | WASF2, HASPIN, MRPL21 | CASP2 1579/4885FAAH 3983/4885TSHR 3953/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.